Molecular Imaging with Glucose Derivatives
October 4, 2005
Location: Nuclear Medicine Library at VGHJim Pattison Pavilion, 855 West 12th Avenue, Vancouver
Presenter: Cara Fisher, University of British Columbia Chemistry Department & PETGroup of TRIUMF
Glucose, a simple sugar, is a basic energy source in the body. The
molecular imaging of glucose metabolism using
2-18F-Fluoro-2-deoxy-D-glucose (FDG) and positron emission
tomography (PET) has proved to be a useful tool for cardiology,
oncology, and neurology. Unfortunately, FDG and PET are costly and
relatively inaccessible, especially in Canada, and FDG has no
therapeutic value.
This presentation will comprise of a basic explanation of how
glucose metabolism imaging works, and the advantages and
disadvantages of FDG and PET. A summary of our work to find
diagnostic alternatives and therapeutic analogues of FDG will be
given, including a discussion on the importance of information
obtained from the data of imaging experiments.
|